Statistics

Total Visits

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study162

Select a period of time:

Number of views in the range

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study66

Views

Views
December 20256
January 202610
February 20260
March 20267
April 202613
May 202613
June 202617
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States18
Netherlands5
Finland5
United Kingdom4
Spain4
Poland3
South Africa3
France3
Argentina2
Brazil2
 

Top cities views

Views
San Jose6
Helsinki5
Madrid4
Groningen4
Tower Hamlets2
Ayacucho1
Belmont1
Bogotá1
Caxias1
Cochabamba1